Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Revenue: 2013-2024

Historic Revenue for ProQR Therapeutics N.V (PRQR) over the last 12 years, with Dec 2024 value amounting to $20.2 million.

  • ProQR Therapeutics N.V's Revenue fell 20.17% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 12.03%. This contributed to the annual value of $20.2 million for FY2024, which is 186.70% up from last year.
  • According to the latest figures from FY2024, ProQR Therapeutics N.V's Revenue is $20.2 million, which was up 186.70% from $7.0 million recorded in FY2023.
  • In the past 5 years, ProQR Therapeutics N.V's Revenue ranged from a high of $20.2 million in FY2024 and a low of $1.6 million during FY2021.
  • Over the past 3 years, ProQR Therapeutics N.V's median Revenue value was $7.0 million (recorded in 2023), while the average stood at $10.3 million.
  • In the last 5 years, ProQR Therapeutics N.V's Revenue soared by 610.58% in 2020 and then crashed by 74.49% in 2021.
  • Yearly analysis of 5 years shows ProQR Therapeutics N.V's Revenue stood at $6.2 million in 2020, then slumped by 74.49% to $1.6 million in 2021, then spiked by 132.10% to $3.7 million in 2022, then soared by 92.17% to $7.0 million in 2023, then skyrocketed by 186.70% to $20.2 million in 2024.